[Fibrocartilaginous lipoma: a clinicopathological analysis of six cases].

Li, H L; Wang, J; Cheng, H; Zhang, S J; Mao, R J

Li, H L; Wang, J; Cheng, H; Zhang, S J; Mao, R J.

Affiliation

Li HL; Department of Pathology, Foshan Traditional Chinese Medicine Hospital, Foshan 528000, China.
Wang J; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
Cheng H; Department of Pathology, the Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
Zhang SJ; Department of Pathology, Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Mao RJ; Department of Pathology, Foshan Traditional Chinese Medicine Hospital, Foshan 528000, China.

Zhonghua Bing Li Xue Za Zhi ; 52(8): 827-831, 2023 Aug 08.

Article in Zh | MEDLINE | ID: mdl-37527988

Subject(s)

Lipoma; Male; Female; Humans; Adult; Middle Aged; Aged; Desmin/analysis; China; Lipoma/pathology; Fibroblasts/pathology; S100 Proteins/analysis; Diagnosis, Differential; Fibrocartilage/chemistry; Fibrocartilage/pathology; Biomarkers, Tumor/analysis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lipoma Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: Zh Journal: Zhonghua Bing Li Xue Za Zhi Year: 2023 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google